1 / 7

Urinary Antibacterial And Antiseptic Pharmaceuticals Market Volume Analysis, Segments, Value Share and Key Trends 2016-2

Urinary tract infection refers to bacterial infection in any part of urinary system such as urethra, ureters, bladder and kidney. Urinary tract infections are common in patients which are using urinary catheter, diabetics and elderly people having compromised immunity. Most of the urinary infections are caused by E. coli and S. aureus. Urinary tract infections are mostly treated with antibacterial drugs such as ciprofloxacin, azithromycin, penicillin and others. Urinary antiseptics such as nalidixic acid, nitrofurantoin etc. can also be effectively used for management of urinary tract infections, these are the drugs which are excreted in urine and show their antiseptic action in the bladder. The choice of treatment depends on type of infectious bacteria and patient history, complicated urinary tract infections leads to kidney damage and may need hospitalization. According to National Institute of Diabetes, Digestive and Kidney Diseases (NIH), urinary tract infection is the second most common type of infection and approximately 8.1 Mn patients visit every year to their physician concerning urinary tract infection.

Monica2016
Download Presentation

Urinary Antibacterial And Antiseptic Pharmaceuticals Market Volume Analysis, Segments, Value Share and Key Trends 2016-2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Urinary Antibacterial And Antiseptic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2016-2026 March 2017 Report Id : REP-GB-1451 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved

  2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research ©2015 Future Market Insights, All Rights Reserved 2

  3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 PMR formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 PMR conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 PMR delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3

  4. Urinary Antibacterial And Antiseptic Pharmaceuticals Market Urinary tract infection refers to bacterial infection in any part of urinary system such as urethra, ureters, bladder and kidney. Urinary tract infections are common in patients which are using urinary catheter, diabetics and elderly people having compromised immunity. Most of the urinary infections are caused by E. coli and S. aureus. Urinary tract infections are mostly treated with antibacterial drugs such as ciprofloxacin, azithromycin, penicillin and others. Urinary antiseptics such as nalidixic acid, nitrofurantoin etc. can also be effectively used for management of urinary tract infections, these are the drugs which are excreted in urine and show their antiseptic action in the bladder. The choice of treatment depends on type of infectious bacteria and patient history, complicated urinary tract infections leads to kidney damage and may need hospitalization. According to National Institute of Diabetes, Digestive and Kidney Diseases (NIH), urinary tract infection is the second most common type of infection and approximately 8.1 Mn patients visit every year to their physician concerning urinary tract infection. Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Drivers and Restraints Increasing recurrence rate for urinary tract infections is the major driver for the growth of urinary antibacterial and antiseptic pharmaceuticals market. Other factors influencing growth of urinary antibacterial and antiseptic pharmaceuticals market can be increasing incidence of diabetes, rising cases of catheter-associated urinary tract infections and expanding indications of drugs, availability of combination products, etc. According to Center for Disease Control and Prevention (CDC), 75% of the hospital acquired urinary tract infections are associated with the catheter use. Major restraint for growth of global market for urinary antibacterial and antiseptic pharmaceuticals is increasing bacterial resistance to antibiotics. Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1451 ©2015 Future Market Insights, All Rights Reserved 4

  5. Urinary Antibacterial And Antiseptic Pharmaceuticals Market Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Overview The global urinary antibacterial and antiseptic pharmaceuticals market is expected to witness sluggish growth due to huge competition between generic players in major markets. Antibacterial product segment is anticipated to hold maximum market as it is the first line treatment for urinary tract infections. Hospital end user segment will continue to lead the global market for urinary antibacterial and antiseptic pharmaceuticals market due to increasing usage of urinary catheters among patients. According to CDC data, 15-25% of all hospitalized patients require catheter use during their hospital stay. Several new treatment options such as monoclonal antibodies are being developed for infection which can influence the market. Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Region-wise Outlook Geographically, the global urinary antibacterial and antiseptic pharmaceuticals market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Europe is anticipated to lead the global market for urinary antibacterial and antiseptic pharmaceutical due to greater incidence community acquired urinary tract infections, followed by North America. However, the market is expected to register decline in revenue in the regions of North America and Europe. The Asia Pacific market for urinary antibacterial and antiseptic pharmaceuticals is anticipated to exhibit moderate growth. Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1451 ©2015 Future Market Insights, All Rights Reserved 5

  6. Urinary Antibacterial And Antiseptic Pharmaceuticals Market Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Key Players Some of the key market players in global urinary and antiseptic pharmaceuticals market are Pfizer Inc., AstraZeneca Plc., Merck & Co., GlaxoSmithKline Plc., Bayer Pharma AG, Johnson & Johnson Private Limited, Daiichi Sankyo Company Limited and others. Browse Full Report@ http://www.futuremarketinsights.com/reports/urinary-antibacterial-and-antiseptic- pharmaceuticals-market ©2015 Future Market Insights, All Rights Reserved 6

  7. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Harish Tiwari (General Manager & Global Head Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You ©2015 Future Market Insights, All Rights Reserved 7

More Related